Cargando…
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells using angiotensin-converting enzyme 2 (ACE2) and neuropilin-1 (NRP-1) as the primary receptor and entry co-factor, respectively. Cell entry is the first and major step in initiation of the viral life cycle, representing an ide...
Autores principales: | Hashizume, Mei, Takashima, Ayako, Ono, Chikako, Okamoto, Toru, Iwasaki, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721373/ https://www.ncbi.nlm.nih.gov/pubmed/36481388 http://dx.doi.org/10.1016/j.antiviral.2022.105481 |
Ejemplares similares
-
Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro
por: Hashizume, Mei, et al.
Publicado: (2021) -
Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
por: Liang, Taizhen, et al.
Publicado: (2023) -
A small stem-loop-forming region within the 3′-UTR of a nonpolyadenylated LCMV mRNA promotes translation
por: Hashizume, Mei, et al.
Publicado: (2022) -
Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
por: Kolarič, Anja, et al.
Publicado: (2022) -
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
por: Cantuti-Castelvetri, Ludovico, et al.
Publicado: (2020)